{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:50:20Z","timestamp":1787165420627,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bpg.2010.07.005","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T12:40:39Z","timestamp":1298032839000},"page":"655-666","source":"Crossref","is-referenced-by-count":52,"title":["Primary sclerosing cholangitis"],"prefix":"10.1016","volume":"24","author":[{"given":"Tom H.","family":"Karlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Schrumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Muri","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2010.07.005_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(80)90131-6","article-title":"Clinicopathologic features of the syndrome of primary sclerosing cholangitis","volume":"79","author":"Wiesner","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hep.1840060403","article-title":"Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis","volume":"6","author":"Ludwig","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2214\/ajr.150.3.571","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"150","author":"Brandt","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2010.07.005_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"Escorsell","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore","volume":"17","author":"Ang","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.005_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00365528709011139","article-title":"Primary sclerosing cholangitis: a long-term follow-up study","volume":"22","author":"Aadland","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/bega.2001.0212","article-title":"Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease","volume":"15","author":"Wiesner","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3109\/00365529409092504","article-title":"Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis","volume":"29","author":"Boberg","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.005_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.005_bib14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpg.2010.07.005_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2010.07.005_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-109-9-713","article-title":"Primary sclerosing cholangitis and celiac disease. A novel association","volume":"109","author":"Hay","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2010.07.005_bib17","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/00365528009181516","article-title":"Sclerosing cholangitis in ulcerative colitis","volume":"15","author":"Schrumpf","year":"1980","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.005_bib24","first-page":"279","article-title":"A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease","volume":"92","author":"Riley","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib26","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with nonsmoking: a case-control study","volume":"110","author":"Sandborn","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib27","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/hep.23564","article-title":"The utility of genome-wide association studies in hepatology","volume":"51","author":"Karlsen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.gene.6364377","article-title":"Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis","volume":"8","author":"Karlsen","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.bpg.2010.07.005_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1572-0241.2006.00928.x","article-title":"Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis","volume":"102","author":"Karlsen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jhep.2007.01.032","article-title":"Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis","volume":"46","author":"Karlsen","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2009.11.029","article-title":"Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C","volume":"52","author":"Hov","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpg.2010.07.005_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.dld.2010.01.011","article-title":"Update on primary sclerosing cholangitis","volume":"42","author":"Karlsen","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.005_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bpg.2010.07.005_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","article-title":"Liver disease in cystic fibrosis","volume":"13","author":"Colombo","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.bpg.2010.07.005_bib39","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00452.2003","article-title":"Induction of colitis in cftr-\/- mice results in bile duct injury","volume":"287","author":"Blanco","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bpg.2010.07.005_bib40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.221","article-title":"Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility","volume":"40","author":"Franke","year":"2008","journal-title":"Nat Genet"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2010.07.005_bib41","first-page":"43","article-title":"Surgical pathology of the syndrome of primary sclerosing cholangitis","volume":"13","author":"Ludwig","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpg.2010.07.005_bib42","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4065\/75.7.688","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bpg.2010.07.005_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.31872","article-title":"Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis","volume":"35","author":"Boberg","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib45","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/0016-5085(92)91449-E","article-title":"Primary sclerosing cholangitis: refinement and validation of survival models","volume":"103","author":"Dickson","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1572-0241.2004.04098.x","article-title":"Endoscopic therapy in primary sclerosing cholangitis. Dominant strictures may not matter: does that mean that endotherapy does not work?","volume":"99","author":"Kozarek","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib48","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/j.1572-0241.2004.40695_4.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis-revisited","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib49","first-page":"251","article-title":"Prognostic value of cholangiography in primary sclerosing cholangitis","volume":"7","author":"Olsson","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib50","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2214\/ajr.157.5.1927817","article-title":"Primary sclerosing cholangitis: value of cholangiography in determining the prognosis","volume":"157","author":"Craig","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2010.07.005_bib51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.005_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolph","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib54","first-page":"265A","article-title":"Variation in the MDR3 gene influences disease progression in PSC patients and disease susceptibility in epistatic interaction with polymorphism in OST-alpha gene","volume":"46","author":"Melum","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib55","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1053\/j.gastro.2006.05.057","article-title":"Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis","volume":"131","author":"Karlsen","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/archinte.130.4.606","article-title":"Bile acids, liver injury, and liver disease","volume":"130","author":"Palmer","year":"1972","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2010.07.005_bib57","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bpg.2010.07.005_bib58","doi-asserted-by":"crossref","first-page":"45062","DOI":"10.1074\/jbc.M307145200","article-title":"Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity","volume":"278","author":"Guo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bpg.2010.07.005_bib59","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1073\/pnas.051014398","article-title":"An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids","volume":"98","author":"Xie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpg.2010.07.005_bib60","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2010.07.005_bib61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib62","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthardt","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib63","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MOG.0b013e3282f5727a","article-title":"Gallbladder polyps in primary sclerosing cholangitis: not so benign","volume":"24","author":"Karlsen","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0168-8278(00)00034-9","article-title":"Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis","volume":"34","author":"Fleming","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib67","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1053\/j.gastro.2005.03.010","article-title":"Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells","volume":"128","author":"Kobayashi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib68","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.freeradbiomed.2005.07.005","article-title":"Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage","volume":"39","author":"Komichi","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bpg.2010.07.005_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib70","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2010.07.005_bib71","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.07.005_bib72","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib73","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"Luth","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.07.005_bib75","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gut.2003.036483","article-title":"Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases","volume":"53","author":"Florin","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.005_bib76","doi-asserted-by":"crossref","first-page":"748","DOI":"10.4065\/71.8.748","article-title":"Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy","volume":"71","author":"Kartheuser","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bpg.2010.07.005_bib77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":"Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis","volume":"38","author":"Penna","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.005_bib78","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cgh.2007.09.018","article-title":"Impact of orthotopic liver transplant for primary sclerosing cholangitis on chronic antibiotic refractory pouchitis","volume":"6","author":"Freeman","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jhep.2007.07.003","article-title":"Cholangiocarcinoma: is transplantation an option? For whom?","volume":"47","author":"Gores","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib80","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.510270308","article-title":"Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation","volume":"27","author":"Loftus","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib81","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib83","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2010.07.005_bib84","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2006-933565","article-title":"Liver transplantation in primary sclerosing cholangitis","volume":"26","author":"Bjoro","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2010.07.005_bib85","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0012.2007.00788.x","article-title":"Late acute rejection after liver transplantation impacts patient survival","volume":"22","author":"Uemura","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bpg.2010.07.005_bib86","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib87","first-page":"S30","article-title":"timing, and risk factors for acute and chronic rejection","volume":"5","author":"Incidence","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.bpg.2010.07.005_bib88","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1600-6143.2008.02341.x","article-title":"Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation","volume":"8","author":"Hanvesakul","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpg.2010.07.005_bib89","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.humimm.2005.10.016","article-title":"Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome","volume":"66","author":"Bishara","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bpg.2010.07.005_bib90","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib91","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2010.07.005_bib92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2010.07.005_bib93","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2010.07.005_bib94","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2010.07.005_bib95","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bpg.2010.07.005_bib96","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpg.2010.07.005_bib97","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/gut.43.5.639","article-title":"Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis","volume":"43","author":"Papatheodoridis","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.07.005_bib98","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2010.07.005_bib99","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpg.2010.07.005_bib100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T13:06:03Z","timestamp":1559999163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691810000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1521691810000843"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2010.07.005","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}